Cited by 26AI in cancer detectionCutaneous lymphoproliferative disorders researchArtificial Intelligence in Healthcare and Education

Artificial intelligence in digital pathology of cutaneous lymphomas: A review of the current state and future perspectives

Open access
Doeleman, Thom, Hondelink, Liesbeth M., Vermeer, Maarten H., van Dijk, Marijke R., Schrader, Anne M.R.·2023·Seminars in Cancer Biology

Abstract

Primary cutaneous lymphomas (CLs) represent a heterogeneous group of T-cell lymphomas and B-cell lymphomas that present in the skin without evidence of extracutaneous involvement at time of diagnosis. CLs are largely distinct from their systemic counterparts in clinical presentation, histopathology, and biological behavior and, therefore, require different therapeutic management. Additional diagnostic burden is added by the fact that several benign inflammatory dermatoses mimic CL subtypes, requiring clinicopathological correlation for definitive diagnosis. Due to the heterogeneity and rarity of CL, adjunct diagnostic tools are welcomed, especially by pathologists without expertise in this field or with limited access to a centralized specialist panel. The transition into digital pathology workflows enables artificial intelligence (AI)-based analysis of patients' whole-slide pathology images (WSIs). AI can be used to automate manual processes in histopathology but, more importantly, can be applied to complex diagnostic tasks, especially suitable for rare disease like CL. To date, AI-based applications for CL have been minimally explored in literature. However, in other skin cancers and systemic lymphomas, disciplines that are recognized here as the building blocks for CLs, several studies demonstrated promising results using AI for disease diagnosis and subclassification, cancer detection, specimen triaging, and outcome prediction. Additionally, AI allows discovery of novel biomarkers or may help to quantify established biomarkers. This review summarizes and blends applications of AI in pathology of skin cancer and lymphoma and proposes how these findings can be applied to diagnostics of CL.

Integrity signals

Registry

Crossref · 10.1016/j.semcancer.2023.06.004

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Doeleman et al.'s weakly supervised models for differentiation of early MF and BIDs on H&E-stained sections achieved mean slide-level classification accuracy around 76%, comparable with the performance of expert pathologists.

    “Recently, Doeleman et al. trained weakly supervised models for the differentiation of early MF and BIDs on H&E-stained sections. The results are encouraging: the mean slide-level classification accuracy was around 76%, comparable with the performance of expert pathologists [37,38].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Doeleman, T., Hondelink, L. M., Vermeer, M. H., van Dijk, M. R., & Schrader, A. M. R.
Affiliations
Leiden University Medical Center (NL)
Corresponding author
Doeleman, Thom
Venue
Seminars in Cancer Biology
Publisher
Elsevier BV
Published
2023-09
Volume
94
Pages
81-88
ISSN
1044-579X (ISSN-L)
OpenAlex
W4380988494
Cited by
26
References
75
Citations by year
2026: 5 · 2025: 10 · 2024: 10 · 2023: 1
FWCI
0.54
Type
journal article
Language
en
Open access
Locations
  • Seminars in Cancer Biology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Dermatology › Cutaneous lymphoproliferative disorders research
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
primary cutaneous lymphoma, artificial intelligence, digital pathology, whole slide images, T-cell lymphoma, B-cell lymphoma, histopathology, diagnostic biomarkers, lymphoma subclassification, skin cancer, outcome prediction
MeSH terms
Artificial Intelligence, Humans, Lymphoma, Skin Neoplasms, Biomarkers, Lymphoma, B-Cell

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review